The presence of tumor-infiltrating CD103+ TRM is associated with improved outcome or recurrence-free survival in many solid human cancers including melanoma, lung, ovarian, cervical, bladder, urothelial, and breast cancer [104]. This evidence concerns the gene ITGAE and melanoma.